Company intelligence / Profile preview

OSTAR Meditech

New Taipei City, New Taipei City, Taiwanostar.com.tw ↗

Ownership: Private
Development stage: Commercial

Overview

OSTAR Meditech offers commercialized, AI-driven medical-grade heart monitoring devices and digital health solutions for remote cardiac care. Their technology provides real-time analysis of heart rhythm data to clinicians and patients, aiming to improve diagnosis, treatment, and prevention of cardiovascular events such as myocardial infarction and stroke. The company’s products are in active use with both consumers/patients and healthcare professionals.

Therapeutic areas: Cardiovascular
Modalities: DeviceDigital health platform
Industry: Physiological Monitoring

Partnerships

None publicly disclosed; may have third-party app integrations for expanded functionality

Beyond the preview

Go deeper on OSTAR Meditech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OSTAR Meditech.

Explore the full profile